cath conf 06-17-2010
SH-102103- AD- APR 2013 Left Atrial Appendage Closure.
Mind the Gap: AF and Evolving Strategies in Anticoagulation Fred M. Kusumoto, MD, FACC Mayo Clinic Tracy Y. Wang, MD, MHS, FACC Duke Clinical Research.
Warfarin.ppt - Thin Blood
ATRIAL FIBRILLATION 2014 GP Update November 2014 Dr Philippa Howlett Clinical Research Fellow.
1. 2 Learning Objectives After taking part in this activity, participants should be better able to: –Assess the significant clinical consequences and.
Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies.
No conflict of interest
IN THE NAME OF GOD. Prevention of Venous Thromboembolism Dr.Shirali.
6. ¿Cuál es la importancia de la función renal en el manejo de los nuevos anticoagulantes orales? J.C. Reverter.
Clinica Pinna Pintor 30.09.2010
PULMONARY EMBOLISM PROF. DR. YESARİ KARTER KARTER.
